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Introduction
Latent tuberculosis infection (LTBI) has a higher risk of
developing the active form in immunosuppressed
patients. Controversy exists regarding the accuracy of
the tuberculin skin test (TST) and methods based on
the production of interferon gamma in the diagnosis of
TB in pediatric and immunosuppressed patients.
Objectives
To contribute to the knowledge about the diagnosis of
LTBI and TB disease in patients with juvenile idiopathic
arthritis (JIA) treated with methotrexate in a high burden
country, evaluating the frequency and evolution before
and after its initiation, agreement between TST and
ELISPOT and sensitivity and specificity of ELISPOT.
Methods
This is an observational prospective longitudinal study
where JIA patients starting methotrexate were evaluated
in relation to clinical and epidemiological data, and
TST and ELISPOT performed at inclusion and 3 and
12 months later.
Results
There were a total of 24 patients. The prevalence of
LTBI at inclusion was 20.8% (5/24 patients). The inci-
dence of LTBI after initiation of immunosuppression
was 26.3% (5/19 patients) and the prevalence of LTBI in
the study as a whole was 41.6% (10/24 patients).
The presence of epidemiological history positive for
TB showed a relative risk of 2.0 for the development of
LTBI. No patient developed TB disease. Only 2 patients
had positive ELISPOT. Its sensitivity was 10%, specificity
92.8% and there was poor agreement between TST and
ELISPOT.
Conclusion
We found a high frequency of LTBI in patients with JIA
and no superiority of ELISPOT compared to TST in the
diagnosis and monitoring. The decision to start treat-
ment for LTBI in immunosuppressed children and ado-
lescents in a high burden country should be based on
the results of TST, as the cost of ELISPOT is much
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